AxoGen, Inc.
AXGN
$43.20
$1.433.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 61.46M | 59.90M | 60.08M | 56.66M | 48.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.46M | 59.90M | 60.08M | 56.66M | 48.56M |
| Cost of Revenue | 15.27M | 15.50M | 14.09M | 14.64M | 13.63M |
| Gross Profit | 46.19M | 44.41M | 45.99M | 42.02M | 34.93M |
| SG&A Expenses | 41.50M | 41.81M | 36.52M | 33.49M | 30.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.29M | 69.68M | 58.17M | 54.99M | 50.22M |
| Operating Income | -2.83M | -9.77M | 1.91M | 1.67M | -1.66M |
| Income Before Tax | -19.58M | -13.16M | 708.00K | 579.00K | -3.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.58M | -13.16M | 708.00K | 579.00K | -3.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.58M | -13.16M | 708.00K | 579.00K | -3.83M |
| EBIT | -2.83M | -9.77M | 1.91M | 1.67M | -1.66M |
| EBITDA | -1.13M | -8.05M | 3.64M | 3.40M | 134.00K |
| EPS Basic | -0.38 | -0.28 | 0.02 | 0.01 | -0.08 |
| Normalized Basic EPS | -0.03 | -0.18 | 0.01 | 0.01 | -0.05 |
| EPS Diluted | -0.38 | -0.28 | 0.01 | 0.01 | -0.08 |
| Normalized Diluted EPS | -0.03 | -0.18 | 0.01 | 0.01 | -0.05 |
| Average Basic Shares Outstanding | 51.59M | 46.93M | 46.49M | 46.06M | 45.20M |
| Average Diluted Shares Outstanding | 51.59M | 46.93M | 49.09M | 47.98M | 45.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |